Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.476 EUR | +0.87% | -5.08% | -26.36% |
Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.36% | 512M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+48.04% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
+27.16% | 12.05B | |
-3.63% | 11.7B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- EU Commission Grants Standard Marketing Authorization to Valneva's COVID-19 Jab